{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:59:00Z","timestamp":1788400740806,"version":"build-2803163510"},"reference-count":61,"publisher":"Edizioni Minerva Medica","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Angiol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.23736\/s0392-9590.23.05084-8","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T13:29:42Z","timestamp":1703251782000},"source":"Crossref","is-referenced-by-count":8,"title":["Reduction of lower-limb edema in patients with chronic venous disease by micronized purified flavonoid fraction: a systematic literature review and meta-analysis"],"prefix":"10.23736","volume":"42","author":[{"given":"Eberharde","family":"RABE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"BLANC-GUILLEMAUD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Blanche","family":"ONSELAER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"BLANGERO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hurrem-Pelin","family":"YALTIRIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"NICOLAIDES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17149","reference":[{"key":"10.23736\/S0392-9590.23.05084-8_ref001","first-page":"105","article-title":"Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program","volume":"31","author":"Rabe E","year":"2012","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.23.05084-8_ref002","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006898"},{"key":"10.23736\/S0392-9590.23.05084-8_ref003","doi-asserted-by":"publisher","DOI":"10.1053\/j.semvascsurg.2021.02.007"},{"key":"10.23736\/S0392-9590.23.05084-8_ref004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra055289"},{"key":"10.23736\/S0392-9590.23.05084-8_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2010.09.025"},{"key":"10.23736\/S0392-9590.23.05084-8_ref006","doi-asserted-by":"publisher","DOI":"10.3390\/medicines9080041"},{"key":"10.23736\/S0392-9590.23.05084-8_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2015.05.013"},{"key":"10.23736\/S0392-9590.23.05084-8_ref008","doi-asserted-by":"publisher","DOI":"10.1177\/00033197050560i101"},{"key":"10.23736\/S0392-9590.23.05084-8_ref009","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2017.06.131"},{"key":"10.23736\/S0392-9590.23.05084-8_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2007.08.011"},{"key":"10.23736\/S0392-9590.23.05084-8_ref011","doi-asserted-by":"publisher","DOI":"10.1177\/00033197050560i102"},{"key":"10.23736\/S0392-9590.23.05084-8_ref012","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000168"},{"key":"10.23736\/S0392-9590.23.05084-8_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2004.02.044"},{"key":"10.23736\/S0392-9590.23.05084-8_ref014","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061669"},{"key":"10.23736\/S0392-9590.23.05084-8_ref015","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.19.04116-6"},{"key":"10.23736\/S0392-9590.23.05084-8_ref016","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.20.04388-6"},{"key":"10.23736\/S0392-9590.23.05084-8_ref017","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.18.03999-8"},{"key":"10.23736\/S0392-9590.23.05084-8_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdmv.2022.04.003"},{"key":"10.23736\/S0392-9590.23.05084-8_ref019","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12694"},{"key":"10.23736\/S0392-9590.23.05084-8_ref020","first-page":"310","article-title":"Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema","volume":"31","author":"Allaert FA","year":"2012","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.23.05084-8_ref021","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.18.03975-5"},{"key":"10.23736\/S0392-9590.23.05084-8_ref022","first-page":"CD003229","article-title":"Phlebotonics for venous insufficiency","volume":"11","author":"Martinez-Zapata MJ","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.23736\/S0392-9590.23.05084-8_ref023","doi-asserted-by":"publisher","DOI":"10.1177\/02683555211015020"},{"key":"10.23736\/S0392-9590.23.05084-8_ref024","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"10.23736\/S0392-9590.23.05084-8_ref025","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. Second Edition: Hillside, NJ: L. Erlbaum Associates; 1988."},{"key":"10.23736\/S0392-9590.23.05084-8_ref026","doi-asserted-by":"publisher","DOI":"10.1007\/S40037-016-0308-Y"},{"key":"10.23736\/S0392-9590.23.05084-8_ref027","first-page":"1","article-title":"Venous Insufficiency and Daflon 500 mg","volume":"9","author":"Planchon B","year":"1990","journal-title":"Arteres Veines"},{"key":"10.23736\/S0392-9590.23.05084-8_ref028","doi-asserted-by":"publisher","DOI":"10.1159\/000179095"},{"key":"10.23736\/S0392-9590.23.05084-8_ref029","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(96)80081-6"},{"key":"10.23736\/S0392-9590.23.05084-8_ref030","first-page":"243","article-title":"Advantages of micronisationof Daflon 500 mg compared with a simple diosmine in the treatment of venous insufficiency. Double blind study","volume":"51","author":"Cospite M","year":"1998","journal-title":"Phlebologie"},{"key":"10.23736\/S0392-9590.23.05084-8_ref031","first-page":"67","article-title":"A long term treatment with a venotropic drug. Results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency","volume":"8","author":"Guillot B","year":"1989","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.23.05084-8_ref032","doi-asserted-by":"publisher","DOI":"10.1177\/153857440003400112"},{"key":"10.23736\/S0392-9590.23.05084-8_ref033","doi-asserted-by":"publisher","DOI":"10.33529\/ANGI02020201"},{"key":"10.23736\/S0392-9590.23.05084-8_ref034","first-page":"137","article-title":"Efficacy of a 6 month treatment with Daflon 500 mg in patients with venous edema","volume":"17","author":"Navratilova Z","year":"2010","journal-title":"Phlebology"},{"key":"10.23736\/S0392-9590.23.05084-8_ref035","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01228-7"},{"key":"10.23736\/S0392-9590.23.05084-8_ref036","first-page":"531","article-title":"Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin","volume":"45","author":"Amato C","year":"1994","journal-title":"Angiology"},{"key":"10.23736\/S0392-9590.23.05084-8_ref037","doi-asserted-by":"publisher","DOI":"10.1177\/026835559400900206"},{"key":"10.23736\/S0392-9590.23.05084-8_ref038","doi-asserted-by":"publisher","DOI":"10.1177\/000331970005100106"},{"key":"10.23736\/S0392-9590.23.05084-8_ref039","doi-asserted-by":"publisher","DOI":"10.1177\/0268355513489550"},{"key":"10.23736\/S0392-9590.23.05084-8_ref040","first-page":"36","article-title":"R","volume":"99","author":"Frileux CG","year":"1987","journal-title":"Les Grandes Etudes Cliniques."},{"key":"10.23736\/S0392-9590.23.05084-8_ref041","first-page":"53","article-title":"Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg","volume":"8","author":"Tsouderos Y","year":"1989","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.23.05084-8_ref042","first-page":"32","author":"Chassignole JF","year":"1994","journal-title":"J Intern Med"},{"key":"10.23736\/S0392-9590.23.05084-8_ref043","doi-asserted-by":"publisher","DOI":"10.1177\/153857440103500604"},{"key":"10.23736\/S0392-9590.23.05084-8_ref044","doi-asserted-by":"publisher","DOI":"10.1177\/000331970205300301"},{"key":"10.23736\/S0392-9590.23.05084-8_ref045","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2021.08.021"},{"key":"10.23736\/S0392-9590.23.05084-8_ref046","first-page":"85","article-title":"Study of the efficacy and acceptability of Daflon 500 mg in 1779 patients with venous insufficiency","volume":"96","author":"Henriet JP","year":"1989","journal-title":"Gazette M\u00e9dicale"},{"key":"10.23736\/S0392-9590.23.05084-8_ref047","first-page":"39","article-title":"Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg","volume":"7","author":"Laurent R","year":"1988","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.23.05084-8_ref048","doi-asserted-by":"publisher","DOI":"10.1177\/0268355594009001s06"},{"key":"10.23736\/S0392-9590.23.05084-8_ref049","first-page":"63","article-title":"The therapeutic activity of Daflon 500 mg in 320 cases of chronic venous insufficiency of the lower limbs","volume":"95","author":"Peker CL","year":"1988","journal-title":"Gazette M\u00e9dicale."},{"key":"10.23736\/S0392-9590.23.05084-8_ref050","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.18.04057-9"},{"key":"10.23736\/S0392-9590.23.05084-8_ref051","doi-asserted-by":"publisher","DOI":"10.1177\/000331979804900301"},{"key":"10.23736\/S0392-9590.23.05084-8_ref052","doi-asserted-by":"publisher","DOI":"10.33160\/yam.2020.11.007"},{"key":"10.23736\/S0392-9590.23.05084-8_ref053","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1621480"},{"key":"10.23736\/S0392-9590.23.05084-8_ref054","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-5"},{"key":"10.23736\/S0392-9590.23.05084-8_ref055","doi-asserted-by":"publisher","DOI":"10.1053\/ejvs.2001.1531"},{"key":"10.23736\/S0392-9590.23.05084-8_ref056","first-page":"374","article-title":"Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum","volume":"35","author":"Perrin M","year":"2016","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.23.05084-8_ref057","doi-asserted-by":"publisher","DOI":"10.1097\/00042728-200812000-00006"},{"key":"10.23736\/S0392-9590.23.05084-8_ref058","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10091754"},{"key":"10.23736\/S0392-9590.23.05084-8_ref059","doi-asserted-by":"publisher","DOI":"10.17140\/WHOJ-6-136"},{"key":"10.23736\/S0392-9590.23.05084-8_ref060","first-page":"56","article-title":"Measuring and representing peripheral oedema and its alterations","volume":"27","author":"Casley-Smith JR","year":"1994","journal-title":"Lymphology"},{"key":"10.23736\/S0392-9590.23.05084-8_ref061","first-page":"140","article-title":"Limb volume estimates based on limb elliptical vs. circular cross section models","volume":"36","author":"Mayrovitz HN","year":"2003","journal-title":"Lymphology"}],"container-title":["International Angiology"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R34Y2023N06A0488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T13:27:55Z","timestamp":1707226075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R34Y2023N06A0488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":61,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.23736\/s0392-9590.23.05084-8","relation":{},"ISSN":["0392-9590","1827-1839"],"issn-type":[{"value":"0392-9590","type":"print"},{"value":"1827-1839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}